Reduced intensity conditioning for allogeneic hematopoietic cell transplantation: current perspectives

Area of Science:

• Hematology
• Oncology
• Transplant Immunology

Background:

• Allogeneic hematopoietic stem cell transplantation (HCT) with myeloablative conditioning is a standard therapy for hematologic malignancies.
• Reduced intensity and nonmyeloablative regimens have been developed to broaden HCT applicability to older patients or those with comorbidities.
• These regimens aim to decrease treatment-related toxicity while leveraging graft-versus-tumor (GVT) effects.

Purpose of the Study:

• To describe representative reduced intensity and nonmyeloablative conditioning approaches in allogeneic HCT.
• To demonstrate the clinical application of these regimens for various malignancies.
• To highlight current challenges and future directions in the field.

Main Methods:

• Review and description of 3 representative reduced intensity and nonmyeloablative conditioning regimens.
• Discussion of clinical applications in hematopoietic and nonhematopoietic malignancies.
• Analysis of challenges, particularly controlling graft-versus-host disease (GVHD) while maintaining GVT effects.

Main Results:

• Reduced intensity and nonmyeloablative conditioning regimens offer alternatives to myeloablative conditioning.
• These approaches demonstrate clinical applicability across different hematologic and nonhematologic malignancies.
• Controlling GVHD while preserving GVT remains a key challenge.

Conclusions:

• Reduced intensity and nonmyeloablative conditioning represent important advancements in allogeneic HCT.
• Further clinical trials are needed to compare these regimens with myeloablative conditioning in selected malignancies.
• The goal is to expand HCT eligibility to a wider patient population, including standard-risk patients.